1106 results about "Boronic acid" patented technology

The present invention provides a composition comprising the product prepared by hearing together: (a) a dispersant; and (b) a 1,3-dicarboxylic acid or 1,4-dicarboxylic acid of an aromatic compound, or a reactive equivalent thereof; and at least one of: (c) 2,5-dimercapto-1,3,4-thiadiazole or a hydrocarbyl-substituted 2,5-dimercapto-1,3,4-thiadiazole, or an oligomer thereof; (d) a borating agent; and (e) a phosphorus acid compound, or a reactive equivalent thereof, said heating being sufficient to provide a reaction product of (a), (b), and (c), (d), or (e), which is soluble in an oil of lubricating viscosity. The invention further provides a use for the composition.

The present invention concerns an electrode carrying immobilized redox enzymes such that electric charge can flow between an electron mediator group to the enzyme cofactor by the use of boronic acid or a boronic acid derivative that acts as a linker moiety between the cofactor and the electron mediator group. The invention also concerns devices and systems that make use of the electrode of the invention, such as biosensors and fuel cells, the electrode being one of the components thereof.

The present invention concerns an improved optical method and optical sensing device for determining the levels of polyhydroxyl-substituted organic molecules in vitro and/or in vivo in aqueous media. In particular, a sensory devise is implemented in a mammal to determine sugar levels. Specifically, a dye is combined with a conjugated nitrogen-containing heterocyclic aromatic boronic acid-substituted bis-onium compound in the presence of a sugar, such as fructose or glucose. The viologens are preferred as the aromatic conjugated nitrogen-containing boronic acid substituted compounds. The method is useful to determine sugar levels in a human being.

A pharmaceutically acceptable base addition salt of an organoboronic acid of formula (XXX):

wherein: P is hydrogen or an amino-group protecting moiety; R is hydrogen or alkyl; A is 0, 1 or 2;

• • R¹, R² and R³ are independently hydrogen, alkyl, cycloalkyl, aryl or —CH₂—R⁵;
  • R⁵, in each instance, is one of aryl, aralkyl, alkaryl, cycloalkyl, heterocyclyl, heteroaryl, or —W—R⁶, where W is a chalcogen and R⁶ is alkyl; and
  • where the ring portion of any of said aryl, aralkyl, alkaryl, cycloalkyl, heterocyclyl, or heteroaryl in R¹, R², R³ or R⁵ can be optionally substituted.

Disclosed are methods and devices for detection of ion migration and binding, utilizing a nanopipette adapted for use in an electrochemical sensing circuit. The nanopipette may be functionalized on its interior bore with metal chelators for binding and sensing metal ions or other specific binding molecules such as boronic acid for binding and sensing glucose. Such a functionalized nanopipette is comprised in an electrical sensor that detects when the nanopipette selectively and reversibly binds ions or small molecules. Also disclosed is a nanoreactor, comprising a nanopipette, for controlling precipitation in aqueous solutions by voltage-directed ion migration, wherein ions may be directed out of the interior bore by a repulsing charge in the bore.

The spectroscopic and photophysical properties of fluorescent probes comprising donor-acceptor derivatives comprising the boric acid group or a derivative of boric acid, B(OH)3 (or borate ion, BO(OH)2<-1>), arsenious acid, H3 AsO3 (or arsenite ion, H2AsO3<-1>), telluric acid, H6TeO6 (or tellurate ion, H5 TeO6<-1>) or germanic acid, Ge(OH)6 (or germanate ion, GeO(OH)3<-1>) are described. Method of using said probes are also provided.

Packaging systems for storing ophthalmic devices such as contact lenses and to methods for packaging such ophthalmic devices with solutions to improve the comfort of the lenses during wear are disclosed. A packaging system includes an ophthalmic device stored in an aqueous packaging solution comprising a brush copolymer comprising (a) monomeric units derived from an ethylenically unsaturated monomer containing one or more boronic acid moieties; and (b) monomeric units derived from an ethylenically unsaturated-containing hydrophilic macromonomer.

The present invention provides a method for detecting an analyte, comprising providing a sensor comprising a substrate coated with a free electron metal, a matrix layer disposed on the free electron metal, the matrix layer comprising an organic compound, wherein the organic compound has a boronic acid complexing moiety and, a boronic acid moiety complexed to the boronic acid complexing moiety; and contacting the sensor with the analyte to elicit a response; and measuring the response thereby detecting the analyte.

Disclosed herein are antimicrobial compounds compositions, pharmaceutical compositions, the use and preparation thereof. Some embodiments relate to boronic acid derivatives and their use as therapeutic agents. Other embodiments relate to pharmaceutical compositions containing boronic acid derivatives and additional excipient such as meglumine.

The present invention is directed to pyrrolidinylaminoacetyl pyrrolidine boronic acid compounds that display selective, potent dipeptidyl peptidase IV inhibitory activity. These compounds are useful for the treatment of disorders that can be regulated or normalized via inhibition of DPP-IV including those characterized by impaired glycemic control such as Diabetes Mellitus and related conditions. The compounds can be administered alone or with another medicament that displays pharmacological activity for treatment of these and other diseases.

Thienothiophenes compositions comprising a C_3-8 secondary or tertiary alkyl group are disclosed. The thienothiophenes may berepresented by the formula:

where R is C_3-8 secondary or tertiary alkyl, e.g., isopropyl, tert-butyl, tert-pentyl, isopentyl, and 2-ethylhexyl, X and X′ are independently selected from the group consisting of H, halogen atoms (e.g., F, Cl, Br, and I), MgCl, MgBr, Mgl, Sn(R′)₃, (where R′ is C_1-6 alkyl or —OC_1-6 alkyl), boronic acid, boronic ester, —CH═CHR″ (where R″ is H or C_1-6 alkyl), —OC_1-6 alkyl, —COOC_1-6 alkyl, —S—COR′″, —COR′″ (where R′″ is H or C_1-6 alkyl), —C≡CH, and polymerizable aromatic rings such as phenyl, naphthalene, pyrrole, dithiophene, thienothiophene, thiophene and so forth.

A multi-layer structure comprising a layer of an ethylene-vinyl alcohol copolymer (A), a layer of a carboxylic acid-modified polyolefin (B), a layer of a thermoplastic resin (C) having a solubility parameter of 11 or less, and a layer of a resin composition (E), wherein the resin composition (E) comprises an ethylene-vinyl alcohol copolymer (A), a carboxylic acid-modified polyolefin (B), a thermoplastic resin (C) and a thermoplastic resin (D) having at least one functional group selected from the group consisting of a boronic acid group and boron-containing groups capable of being converted into a boronic acid group in the presence of water, and the layer of an ethylene-vinyl alcohol copolymer (A) is laminated with the layer of a thermoplastic resin (C) or the layer of a resin composition (E) through the layer of a carboxylic acid-modified polyolefin (B). This provides a multi-layer structure which allows effective reuse of regrind and which is excellent in impact resistance and gas barrier properties.

Polymeric nanoaggregate drug-delivery compositions including boron-containing copolymers are described. The drug-delivery compositions may further include a therapeutic agent comprising a nucleic acid, a polynucletide, a peptide, a polypeptide, a protein, a pharmaceutical or any combinations thereof. Methods for making the polymeric nanoaggregate compositions including at least one therapeutic agent (for example, insulin) as well as methods for administration of these compositions to mammals are also set forth. The disclosure also describes compositions and methods for controlled drug delivery. Further, polymeric nanoaggregate boron-containing compositions including insulin and methods for monitoring and regulating blood glucose levels of a mammal are also described. The disclosure also describes methods for treatment and/or control of diabetes mellitus by administering polymeric nanoaggregate boron-containing compositions including insulin to a mammal in need.

The invention relates to the synthesis of boronic ester and acid compounds. More particularly, the invention provides improved synthetic processes for the large-scale production of boronic ester and acid compounds, including the peptide boronic acid proteasome inhibitor bortezomib.

The present invention is related to glucose sensors that are capable of detecting the concentration or level of glucose in a solution or fluid having either low or high ionic strength. The glucose sensors of the present invention comprise a polymerized crystalline colloidal array (PCCA) and a molecular recognition component capable of responding to glucose. The molecular recognition component may be a boronic acid, such as a phenylboronic acid, glucose oxidase, a combination of phenylboronic acid and poly(ethylene)glycol or crown ether, or another component capable of detecting glucose in various fluids and solutions. The glucose sensors of the present invention may be useful in the development of noninvasive or minimally invasive in vivo glucose sensors for patients having diabetes mellitus.

Small Molecule Metabolite Reporters (SMMRs) for use as in vivo glucose biosensors, sensor compositions, and methods of use, are described. The SMMRs include boronic acid-containing xanthene, coumarin, carbostyril and phenalene-based small molecules which are used for monitoring glucose in vivo, advantageously on the skin.

The invention discloses a special liquid rooting fertilizer for vegetables as well as a preparation method and an application of the special liquid rooting fertilizer. The rooting fertilizer consists of the following components in parts by mass: 100-150 parts of potassium nitrate, 100-150 parts of urea, 100-150 parts of potassium dihydrogen phosphate, 40-80 parts of fulvic acid, 10-50 parts of molasses, 10-50 parts of calcium ammonium nitrate, 10-50 parts of composite amino acid solution, 5-10 parts of ethylene diamine tetraacetic acid (EDTA) iron, 5-10 parts of ethylene diamine tetraacetic acid (EDTA) zinc, 5-10 parts of boric acid, 5-10 parts of sodium alginate, 5-10 parts of alpha-pimacol and 500-800 parts of water. The rooting fertilizer disclosed by the invention, through mutual matching and combined action of various components and contents, can achieve a remarkable rooting effect, and is simple and convenient to use, and is a product which is remarkable in effect on promoting root development of the transplanted vegetables.

Disclosed herein are antimicrobial compounds compositions, pharmaceutical compositions, the use and preparation thereof. Some embodiments relate to boronic acid derivatives and their use as therapeutic agents.

Disclosed herein are antimicrobial compounds compositions, pharmaceutical compositions, the use and preparation thereof. Some embodiments relate to boronic acid derivatives and their use as therapeutic agents.

The invention discloses a fully glazed ceramic chip and a preparation method of the fully glazed ceramic chip. The fully glazed ceramic chip comprises a green body layer, a ground coat layer, an overglazed layer and a fancy glaze layer. A fully glazed layer is arranged on the surface of the fancy glaze layer. The fully glazed layer comprises 64-71% of fully glazed smelted blocks, 0-7% of clinker, 25-32% of water, and 0.1-0.5% of auxiliary materials by weight percentage, wherein materials used by the fully glazed smelted blocks comprise potash feldspar, calcite, burned talc, zinc oxide, boronic acid, barium carbonate, aluminum oxide and quartz, and the clinker is qidao clay or kaolin. The fully glazed ceramic chip provided by the invention is used for ceramic chip decoration, and the glazing effect of the ceramic chip is good, the transparency of the enamel layer and the evenness are high, and the ceramic chip polished is bright so as to represent the clear texture level and rich texture of pictures under glazes, and the brick deformation is small, the thermal shock resistance is good, the mirror finish effect is good, and the transparent texture is excellent.

Crystalline COFs comprising a phthalocyanine moiety and a boron-containing multifunctional linking group joined by boronate ester bonds. A method for making crystalline COFs comprising Lewis acid catalyzed formation of boronate ester bonds between protected catechol subunits and multifunctional linkers comprising boronic acid groups. The COFs can be used in applications such as, for example, electronic devices.

Disclosed herein are antimicrobial compounds compositions, pharmaceutical compositions, the use and preparation thereof. Some embodiments relate to boronic acid derivatives and their use as therapeutic agents.

Biocompatible matrices or implants on which one or more specific cell-interactive molecules (“biomolecules”) can be immobilized have been developed. The matrices allow for the independent control of ligand concentration and matrix strength. In one embodiment, the matrix or implant is modified with one or more moieties capable of complexing bioconjugates prepared from one or more biomolecules. Suitable moieties include phenyl boronic acid complexing agents, such as salicylhydroxamic acid, which can complex to one or more biomolecules containing one or more phenyl boronic acid moieties. The biomolecules may be anchored to the matrix via a spacer molecule, which may allow for greater mobility of the biomolecules in aqueous solution. In one embodiment, the matrix is a hydrogel material which has been doubly-derivatized, wherein ligand concentration and matrix strength can be independently controlled. The matrices and implants can be used in vivo and in vitro applications including diagnostics, biosensors, bioprocess engineering, tissue engineering, regeneration and repair, and drug delivery.

Disclosed herein are antimicrobial compounds compositions, pharmaceutical compositions, the use and preparation thereof. Some embodiments relate to cyclic boronate compounds and their use as therapeutic agents.

Disclosed are biomedical devices having a hydrophilic coating on a portion of a surface thereof, the biomedical device comprising: (a) a biomedical device obtained from a polymerization product of a monomeric mixture comprising (i) a polymerizable monomer containing a boronic acid moiety and an electron withdrawing moiety; and (ii) a biomedical device-forming comonomer; and (b) a hydrophilic reactive polymer having complementary reactive functionalities along the polymer chain, wherein the complementary reactive functionalities along the polymer chain of the hydrophilic reactive polymer of (b) bind with the boronic acid moieties of the biomedical device of (a), thereby producing a biocompatible coating which can be removed and re-applied to restore the surface properties of the biomedical device to substantially as-new condition. Methods for treating the biomedical device are also disclosed.

The invention discloses a nano-selenium-containing amino acid foliar fertilizer and a preparation method thereof. The nano-selenium-containing amino acid foliar fertilizer is prepared from such raw materials as molasses, animal hair, selenium dioxide, sulfuric acid, copper sulfate, manganese sulfate, zinc oxide, ferrous sulfate, ammonium carbonate, ammonium molybdate, urea, potassium chloride, boric acid, fulvic acid, a surfactant, ethylene glycol, sodium carbonate, quick lime or calcium hydroxide, phosphoric acid and water. The preparation comprises the steps of reducing selenium dioxide by use of the molasses to obtain nano-selenium, hydrolyzing the animal hair into an amino acid solution, and then performing the reactions of neutralization, complexing, emulsification and the like to obtain the nano-selenium-containing amino acid foliar fertilizer. According to the nano-selenium-containing amino acid foliar fertilizer, the problem of transforming inorganic selenium into nano-selenium and the problem of recycling waste both are solved; the fertilizer is capable of improving the water retention and drought resisting capability of plants and increasing the content of the organic selenium element content in crops; the preparation method of the fertilizer is mild in reaction conditions, simple in process, relatively low in production cost and prone to industrial production, and has excellent economic benefit, social benefit and ecologic benefit.

The present invention is directed to pyrrolidinylaminoacetyl pyrrolidine boronic acid compounds that display selective, potent dipeptidyl peptidase IV (DPP-IV) inhibitory activity. These compounds are useful for the treatment of disorders that can be regulated or normalized via inhibition of DPP-IV including those characterized by impaired glycemic control such as Diabetes Mellitus and related conditions. The compounds can be administered alone or with another medicament that displays pharmacological activity for treatment of these and other diseases.

Embodiments of the present disclosure relate to analyte determining methods and devices (e.g., electrochemical analyte monitoring systems) that have improved uniformity of distribution and/or improved sensitivity and/or reduced sensitivity variation of the sensing layer by inclusion of a thickener and/or an enzyme stabilizer in the sensing layer. Embodiments of the present disclosure also relate to transition metal complexes having at least one pyridine boronic acid ligand are also described. Aspects of the disclosure include transition metal complexes chemically bonded to a polymer, such as a sensing layer polymer. The sensing layer is disposed on a working electrode of in vivo and/or in vitro analyte sensors, e.g., continuous and/or automatic in vivo monitoring using analyte sensors and/or test strips. Also provided are systems and methods of using the, for example electrochemical, analyte sensors in analyte monitoring.

General methods for the solution phase as well as solid phase synthesis of various substituted heteroaryls has been demonstrated. These substituted heteroaryls can be further elaborated by aromatic substitution with amines at elevated temperature or by anilines, boronic acids and phenols via palladium catalyzed cross-coupling reactions.

The invention discloses a preparation method of Boscalid, which comprises the following steps that Suzuki coupling reaction occurs between o-iodoaniline and 4-chlorobenzene boronic acid to produce an intermediate product 4'-chlorinated biphenyl-2-amine under the catalytic effect of Pd/C by using methylbenzene and alkaline water as mixed solvent; and condensation reaction occurs between the 4'-chlorinated biphenyl-2-amine and 2-chloronicotinyl chloride to produce the Boscalid. The preparation method of the Boscalid has the advantages that the production cost is reduced, the yield of the intermediate product 4'-chlorinated biphenyl-2-amine is improved, the total yield of the two steps exceeds 84 percent and the industrial production is expected to be realized.